A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction

Marco Demaria, Carlotta Diorgi, Magdalena Lebiedzinska, Giovanna Esposito, Luca D'Angeli, Antonietta Bartoli, Daniel James Gough, James Turkson, David E Levy, Christine J Watson, Mariusz R Wieckowski, Paolo Provero, Paolo Pinton, Valeria Poli

Research output: Contribution to journalArticleResearchpeer-review

176 Citations (Scopus)


The pro-oncogenic transcription factor STAT3 is constitutively activated in a wide variety of tumours that often become addicted to its activity, but no unifying view of a core function determining this widespread STAT3-dependence has yet emerged. We show here that constitutively active STAT3 acts as a master regulator of cell metabolism, inducing aerobic glycolysis and down-regulating mitochondrial activity both in primary fibroblasts and in STAT3-dependent tumour cell lines. As a result, cells are protected from apoptosis and senescence while becoming highly sensitive to glucose deprivation. We show that enhanced glycolysis is dependent on HIF-1alpha up-regulation, while reduced mitochondrial activity is HIF-1alpha-independent and likely caused by STAT3-mediated down-regulation of mitochondrial proteins. The induction of aerobic glycolysis is an important component of STAT3 pro-oncogenic activities, since inhibition of STAT3 tyrosine phosphorylation in the tumour cell lines down-regulates glycolysis prior to leading to growth arrest and cell death, both in vitro and in vivo. We propose that this novel, central metabolic role is at the core of the addiction for STAT3 shown by so many biologically different tumours.
Original languageEnglish
Pages (from-to)823-842
Number of pages20
Issue number11
Publication statusPublished - 2010
Externally publishedYes

Cite this